HDFC Sec Recommends OFSS, SUNPHARMA Amidst Market Selloff: Mixed Cues

Indian equity markets experienced a sharp decline, with Sensex and Nifty 50 falling over 1% and erasing significant investor wealth. Despite this broad market correction, Vinay Rajani of HDFC Securities has issued 'buy' recommendations for specific stocks, namely Oracle Financial Services and Sun Pharma.

This matters for traders as it highlights potential defensive or value plays identified by analysts during a bearish market phase. While the overall market sentiment is negative, these recommendations suggest that certain stocks may offer resilience or growth opportunities, providing a counter-narrative to the general market downturn.

The recommendations are positive for OFSS and SUNPHARMA, potentially attracting buying interest even as the broader market corrects. Previous recommendations for NLCINDIA and APOLLOHOSP also suggest continued analyst confidence. The IT and Pharma sectors, often considered defensive, might see increased investor attention as a flight to quality during market volatility.

Traders should monitor the performance of these recommended stocks relative to the broader market. Look for sustained buying interest or price stability in OFSS and SUNPHARMA. Also, observe if other analysts echo similar sentiments for these stocks or if the broader market correction deepens, potentially creating more attractive entry points.

• •Indian equity markets saw a significant selloff on May 18, with Sensex and Nifty 50 dropping over 1%.
• •BSE Sensex fell over 1,000 points, erasing nearly ₹9 lakh crore in investor wealth.
• •Vinay Rajani of HDFC Sec suggests Oracle Financial Services and Sun Pharma shares to buy.
• •Vinay Rajani previously suggested NLC India and Apollo Hospitals shares to buy.
• •Risk flag: Increased USFDA scrutiny or adverse regulatory changes